
Ceftriguard S 250mg/125mg Injection
Marketer
Igniva Marketing Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Ceftriguard S 250mg/125mg Injection
Combiflox, a 250mg/125mg injectable antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be solely under a physician's guidance. Complete the prescribed dosage regimen; premature cessation may compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening symptoms or allergic reactions (rash, pruritus, edema, dyspnea) immediately. Inform your doctor of all concurrent medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid operating machinery if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Your physician may order tests to monitor treatment response.
Uses of Ceftriguard S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Ceftriguard S 250mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Ceftriguard S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ceftriguard S 250mg/125mg Injection:
This medication will be administered by your physician or their associate; please do not attempt self-medication.
How Ceftriguard S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Ceftriguard S 250mg/125mg Injection, offer a dual-action antibacterial approach. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, complements this by neutralizing enzymes that bacteria use to resist the effects of Ceftriaxone, thus improving its efficacy.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Ceftriguard S 250mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation Ceftriguard S (250mg/125mg) is typically deemed safe for use in pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; however, data from human studies remains scarce.
Breast feedingCAUTION
The administration of Ceftriguard S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. It is recommended to discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Ceftriguard S 250mg/125mg Injection could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Ceftriguard S 250mg/125mg Injection administration to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The 250mg/125mg Ceftriguard S injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for this injection is not suggested for those with mild or moderate liver dysfunction.
What if you forget to take Ceftriguard S 250mg/125mg Injection :
Should you forget a Ceftriguard S 250mg/125mg Injection dose, seek your physician's advice.
Facts to Know About Ceftriguard S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
